Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life

Documenti analoghi

• Modelling and assessment of glucose‐lactate kinetics in youth with overweight, obesity and metabolic dysfunction‐associated steatotic liver disease: A pilot study
  di: Jacopo Bonet, et al.
  Pubblicazione: (2024)
• Improved health‐related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT ‐5 trial
  di: Alpana P. Shukla, et al.
  Pubblicazione: (2025)
• The real‐life experiences of people living with overweight and obesity: A psychosocial perspective
  di: Stuart W. Flint, et al.
  Pubblicazione: (2025)
• Tirzepatide and health‐related quality of life in adults with obesity or overweight: Results from the SURMOUNT ‐3 phase 3 randomized trial
  di: Theresa Hunter Gibble, et al.
  Pubblicazione: (2025)
• Characterization of brain morphology associated with metabolic dysfunction‐associated steatotic liver disease in the UK Biobank
  di: Wenxiao Fan, et al.
  Pubblicazione: (2025)